🇺🇸 FDA

Company profile · Sponsor

Seqirus

Seqirus (Australia) Pty Ltd

E60418A · TGA pharma AU
Pipeline
9
Drugs
11
Patents
0

Quick answer

Seqirus (E60418A) is a pharma company. headquartered in AU. listed on TGA. NovaPharmaNews links 9 pipeline programs, 11 drugs, and 0 patents to this profile..

Company facts

Ticker E60418A
Exchange TGA
Company type pharma
Headquarters AU

Pipeline (9)

Search pipeline →

  1. Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV)

    Seqirus

    Influenza Virus

    phase 3 mab completed

    1 trial

  2. Influenza Virus Vaccine

    Seqirus

    Influenza

    phase 3 mab completed

    1 trial

  3. Investigational aQIVc

    Seqirus

    Influenza, Human

    phase 3 mab completed

    1 trial

  4. MF59-adjuvanted Quadrivalent Subunit Inactivated Egg-derived Influenza Vaccine (aQIV)

    Seqirus

    Influenza

    phase 3 mab completed

    1 trial

  5. QIVc

    Seqirus

    Influenza, Human

    phase 3 mab completed

    1 trial

  6. aQIV or aTIV

    Seqirus

    Influenza, Human

    phase 3 mab active

    1 trial

  7. H5N1 antigen combined with MF59 adjuvant

    Seqirus

    Influenza, Human

    phase 2 mab completed

    1 trial

  8. Trivalent influenza vaccine (TIVc)

    Seqirus

    Influenza

    phase 2 mab completed

    1 trial

  9. CSL Limited Influenza Vaccine

    Seqirus

    Influenza

    approved mab completed

    1 trial

Drugs (11)

Search drugs →

  1. avacopan

    TAVNEOS

    ORAL approved

    L04

  2. difelikefalin

    KORSUVA

    V03AX

  3. diphtheria + tetanus vaccine

    ADT BOOSTER

  4. ferric carboxymaltose

    FERINJECT

    INTRAVENOUS approved

  5. icosapent ethyl

    VAZKEPA

    ORAL approved

    C10AX

  6. iron sucrose

    VENOFER

    INTRAVENOUS approved

  7. liquid paraffin + glycerol + tyloxapol + poloxamer-188 + trometamol hydrochloride + trometamol + cetalkonium chloride

    CATIONORM

  8. patiromer

    VELTASSA

    V03AE09

  9. sucroferric oxyhydroxide

    VELPHORO

    V03AE05

  10. tapentadol

    PALEXIA SR

    ORAL approved

  11. tramadol

    TRAMAL

Frequently asked questions

What is Seqirus?

Seqirus (E60418A) is a pharma company. headquartered in AU. listed on TGA. NovaPharmaNews links 9 pipeline programs, 11 drugs, and 0 patents to this profile..

What pipeline programs does Seqirus sponsor?

We track 9 ClinicalTrials.gov-linked programs for Seqirus, including Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and 8 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Seqirus company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.